APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valsartan Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Valsartan Tablets Market Outlook and Growth Opportunities 2026

2 January 2026190 pages

Choose your research edition.

Industry ResearchValsartan Tablets Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Tablets Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Valsartan Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Tablets Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Valsartan Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Valsartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valsartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valsartan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Valsartan Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Valsartan Tablets market include Alembic, Aurobindo, Cadista, Camber, Lupin, Major, Repackagers, Solco Healthcare and Changzhou Siyao Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valsartan Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valsartan Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valsartan Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valsartan Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Valsartan Tablets Segment by Company

Alembic

Aurobindo

Cadista

Camber

Lupin

Major

Repackagers

Solco Healthcare

Changzhou Siyao Pharmaceutical

Mylan

Teva

Zhejiang Huahai Pharm

Valsartan Tablets Segment by Type

80mg

40mg

320mg

160mg

Valsartan Tablets Segment by Application

Clinic

Hospital

Recovery Center

Valsartan Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Valsartan Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Valsartan Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Valsartan Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Valsartan Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valsartan Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Valsartan Tablets industry.

Chapter 3: Detailed analysis of Valsartan Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Valsartan Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Valsartan Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Valsartan Tablets Industry Trends Table 2. Valsartan Tablets Industry Drivers Table 3. Valsartan Tablets Industry Opportunities and Challenges Table 4. Valsartan Tablets Industry Restraints Table 5. Global Valsartan Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Valsartan Tablets Revenue Share by Company (2021-2026) Table 7. Global Valsartan Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Valsartan Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Valsartan Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Valsartan Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Valsartan Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Valsartan Tablets Company, Product Type & Application Table 13. Global Valsartan Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Valsartan Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 80mg Table 18. Significant Companies of 40mg Table 19. Significant Companies of 320mg Table 20. Significant Companies of 160mg Table 21. Global Valsartan Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Valsartan Tablets Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Valsartan Tablets Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Valsartan Tablets Sales Volume Share by Type (2021-2026) Table 25. Global Valsartan Tablets Sales Volume Share by Type (2027-2032) Table 26. Global Valsartan Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Valsartan Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Valsartan Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Valsartan Tablets Sales Value Share by Type (2021-2026) Table 30. Global Valsartan Tablets Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Clinic Table 32. Significant Companies of Hospital Table 33. Significant Companies of Recovery Center Table 34. Global Valsartan Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Valsartan Tablets Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Valsartan Tablets Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Valsartan Tablets Sales Volume Share by Application (2021-2026) Table 38. Global Valsartan Tablets Sales Volume Share by Application (2027-2032) Table 39. Global Valsartan Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Valsartan Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Valsartan Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Valsartan Tablets Sales Value Share by Application (2021-2026) Table 43. Global Valsartan Tablets Sales Value Share by Application (2027-2032) Table 44. Global Valsartan Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Valsartan Tablets Sales by Region (2021-2026) & (K Units) Table 46. Global Valsartan Tablets Sales Market Share by Region (2021-2026) Table 47. Global Valsartan Tablets Sales by Region (2027-2032) & (K Units) Table 48. Global Valsartan Tablets Sales Market Share by Region (2027-2032) Table 49. Global Valsartan Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Valsartan Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Valsartan Tablets Sales Value Share by Region (2021-2026) Table 52. Global Valsartan Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Valsartan Tablets Sales Value Share by Region (2027-2032) Table 54. Global Valsartan Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Valsartan Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Valsartan Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Valsartan Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Valsartan Tablets Sales by Country (2021-2026) & (K Units) Table 59. Global Valsartan Tablets Sales Market Share by Country (2021-2026) Table 60. Global Valsartan Tablets Sales by Country (2027-2032) & (K Units) Table 61. Global Valsartan Tablets Sales Market Share by Country (2027-2032) Table 62. Global Valsartan Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Valsartan Tablets Sales Value Market Share by Country (2021-2026) Table 64. Global Valsartan Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Valsartan Tablets Sales Value Market Share by Country (2027-2032) Table 66. Alembic Company Information Table 67. Alembic Business Overview Table 68. Alembic Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Alembic Valsartan Tablets Product Portfolio Table 70. Alembic Recent Development Table 71. Aurobindo Company Information Table 72. Aurobindo Business Overview Table 73. Aurobindo Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Aurobindo Valsartan Tablets Product Portfolio Table 75. Aurobindo Recent Development Table 76. Cadista Company Information Table 77. Cadista Business Overview Table 78. Cadista Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Cadista Valsartan Tablets Product Portfolio Table 80. Cadista Recent Development Table 81. Camber Company Information Table 82. Camber Business Overview Table 83. Camber Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Camber Valsartan Tablets Product Portfolio Table 85. Camber Recent Development Table 86. Lupin Company Information Table 87. Lupin Business Overview Table 88. Lupin Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Lupin Valsartan Tablets Product Portfolio Table 90. Lupin Recent Development Table 91. Major Company Information Table 92. Major Business Overview Table 93. Major Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Major Valsartan Tablets Product Portfolio Table 95. Major Recent Development Table 96. Repackagers Company Information Table 97. Repackagers Business Overview Table 98. Repackagers Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Repackagers Valsartan Tablets Product Portfolio Table 100. Repackagers Recent Development Table 101. Solco Healthcare Company Information Table 102. Solco Healthcare Business Overview Table 103. Solco Healthcare Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Solco Healthcare Valsartan Tablets Product Portfolio Table 105. Solco Healthcare Recent Development Table 106. Changzhou Siyao Pharmaceutical Company Information Table 107. Changzhou Siyao Pharmaceutical Business Overview Table 108. Changzhou Siyao Pharmaceutical Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Changzhou Siyao Pharmaceutical Valsartan Tablets Product Portfolio Table 110. Changzhou Siyao Pharmaceutical Recent Development Table 111. Mylan Company Information Table 112. Mylan Business Overview Table 113. Mylan Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Mylan Valsartan Tablets Product Portfolio Table 115. Mylan Recent Development Table 116. Teva Company Information Table 117. Teva Business Overview Table 118. Teva Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Teva Valsartan Tablets Product Portfolio Table 120. Teva Recent Development Table 121. Zhejiang Huahai Pharm Company Information Table 122. Zhejiang Huahai Pharm Business Overview Table 123. Zhejiang Huahai Pharm Valsartan Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Zhejiang Huahai Pharm Valsartan Tablets Product Portfolio Table 125. Zhejiang Huahai Pharm Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Valsartan Tablets Distributors List Table 129. Valsartan Tablets Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Valsartan Tablets Product Image Figure 2. Global Valsartan Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Valsartan Tablets Sales (2021-2032) & (K Units) Figure 5. Global Valsartan Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Valsartan Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 80mg Image Figure 10. 40mg Image Figure 11. 320mg Image Figure 12. 160mg Image Figure 13. Global Valsartan Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Valsartan Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Valsartan Tablets Sales Volume Share by Type (2021-2032) Figure 16. Global Valsartan Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Valsartan Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Valsartan Tablets Sales Value Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. Recovery Center Image Figure 22. Global Valsartan Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Valsartan Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Valsartan Tablets Sales Volume Share by Application (2021-2032) Figure 25. Global Valsartan Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Valsartan Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Valsartan Tablets Sales Value Share by Application (2021-2032) Figure 28. Global Valsartan Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Valsartan Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Valsartan Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Valsartan Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Valsartan Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. North America Valsartan Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Valsartan Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Valsartan Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Valsartan Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Valsartan Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Valsartan Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. South America Valsartan Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Valsartan Tablets Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Valsartan Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Valsartan Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Valsartan Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Valsartan Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Valsartan Tablets Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Valsartan Tablets Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 80mg
  • 40mg
  • 320mg
  • 160mg
Applications
  • Clinic
  • Hospital
  • Recovery Center
Companies covered
  • Alembic
  • Aurobindo
  • Cadista
  • Camber
  • Lupin
  • Major
  • Repackagers
  • Solco Healthcare
  • Changzhou Siyao Pharmaceutical
  • Mylan
  • Teva
  • Zhejiang Huahai Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valsartan Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Valsartan Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Valsartan Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Valsartan Tablets Market Dynamics
  1. 2.1 Valsartan Tablets Industry Trends
  2. 2.2 Valsartan Tablets Industry Drivers
  3. 2.3 Valsartan Tablets Industry Opportunities and Challenges
  4. 2.4 Valsartan Tablets Industry Restraints
3 Valsartan Tablets Market by Company
  1. 3.1 Global Valsartan Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Valsartan Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Valsartan Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Valsartan Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Valsartan Tablets Company Ranking (2024-2026)
  6. 3.6 Global Valsartan Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Valsartan Tablets Company Product Type and Application
  8. 3.8 Global Valsartan Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Valsartan Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Valsartan Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Valsartan Tablets Market by Type
  1. 4.1 Valsartan Tablets Type Introduction
  2. 4.1.1 80mg
  3. 4.1.2 40mg
  4. 4.1.3 320mg
  5. 4.1.4 160mg
  6. 4.2 Global Valsartan Tablets Sales Volume by Type
  7. 4.2.1 Global Valsartan Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Valsartan Tablets Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Valsartan Tablets Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Valsartan Tablets Sales Value by Type
  11. 4.3.1 Global Valsartan Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Valsartan Tablets Sales Value by Type (2021-2032)
  13. 4.3.3 Global Valsartan Tablets Sales Value Share by Type (2021-2032)
5 Valsartan Tablets Market by Application
  1. 5.1 Valsartan Tablets Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Valsartan Tablets Sales Volume by Application
  6. 5.2.1 Global Valsartan Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Valsartan Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Valsartan Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Valsartan Tablets Sales Value by Application
  10. 5.3.1 Global Valsartan Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Valsartan Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Valsartan Tablets Sales Value Share by Application (2021-2032)
6 Valsartan Tablets Regional Sales and Value Analysis
  1. 6.1 Global Valsartan Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valsartan Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Valsartan Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Valsartan Tablets Sales by Region (2027-2032)
  5. 6.3 Global Valsartan Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Valsartan Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Valsartan Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Valsartan Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Valsartan Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Valsartan Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Valsartan Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Valsartan Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Valsartan Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Valsartan Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Valsartan Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Valsartan Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Valsartan Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Valsartan Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Valsartan Tablets Sales Value Share by Country, 2025 VS 2032
7 Valsartan Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Valsartan Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Valsartan Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Valsartan Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Valsartan Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Valsartan Tablets Sales by Country (2027-2032)
  6. 7.4 Global Valsartan Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Valsartan Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Valsartan Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Valsartan Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Valsartan Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Valsartan Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Valsartan Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Valsartan Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Valsartan Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Valsartan Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Valsartan Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Valsartan Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Valsartan Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Valsartan Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Valsartan Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Valsartan Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Valsartan Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Valsartan Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Valsartan Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Valsartan Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Valsartan Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Valsartan Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Valsartan Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Valsartan Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Valsartan Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Valsartan Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Valsartan Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Valsartan Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Valsartan Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Valsartan Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Valsartan Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Valsartan Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Valsartan Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alembic
  2. 8.1.1 Alembic Company Information
  3. 8.1.2 Alembic Business Overview
  4. 8.1.3 Alembic Valsartan Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alembic Valsartan Tablets Product Portfolio
  6. 8.1.5 Alembic Recent Developments
  7. 8.2 Aurobindo
  8. 8.2.1 Aurobindo Company Information
  9. 8.2.2 Aurobindo Business Overview
  10. 8.2.3 Aurobindo Valsartan Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Aurobindo Valsartan Tablets Product Portfolio
  12. 8.2.5 Aurobindo Recent Developments
  13. 8.3 Cadista
  14. 8.3.1 Cadista Company Information
  15. 8.3.2 Cadista Business Overview
  16. 8.3.3 Cadista Valsartan Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cadista Valsartan Tablets Product Portfolio
  18. 8.3.5 Cadista Recent Developments
  19. 8.4 Camber
  20. 8.4.1 Camber Company Information
  21. 8.4.2 Camber Business Overview
  22. 8.4.3 Camber Valsartan Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Camber Valsartan Tablets Product Portfolio
  24. 8.4.5 Camber Recent Developments
  25. 8.5 Lupin
  26. 8.5.1 Lupin Company Information
  27. 8.5.2 Lupin Business Overview
  28. 8.5.3 Lupin Valsartan Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lupin Valsartan Tablets Product Portfolio
  30. 8.5.5 Lupin Recent Developments
  31. 8.6 Major
  32. 8.6.1 Major Company Information
  33. 8.6.2 Major Business Overview
  34. 8.6.3 Major Valsartan Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Major Valsartan Tablets Product Portfolio
  36. 8.6.5 Major Recent Developments
  37. 8.7 Repackagers
  38. 8.7.1 Repackagers Company Information
  39. 8.7.2 Repackagers Business Overview
  40. 8.7.3 Repackagers Valsartan Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Repackagers Valsartan Tablets Product Portfolio
  42. 8.7.5 Repackagers Recent Developments
  43. 8.8 Solco Healthcare
  44. 8.8.1 Solco Healthcare Company Information
  45. 8.8.2 Solco Healthcare Business Overview
  46. 8.8.3 Solco Healthcare Valsartan Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Solco Healthcare Valsartan Tablets Product Portfolio
  48. 8.8.5 Solco Healthcare Recent Developments
  49. 8.9 Changzhou Siyao Pharmaceutical
  50. 8.9.1 Changzhou Siyao Pharmaceutical Company Information
  51. 8.9.2 Changzhou Siyao Pharmaceutical Business Overview
  52. 8.9.3 Changzhou Siyao Pharmaceutical Valsartan Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Changzhou Siyao Pharmaceutical Valsartan Tablets Product Portfolio
  54. 8.9.5 Changzhou Siyao Pharmaceutical Recent Developments
  55. 8.10 Mylan
  56. 8.10.1 Mylan Company Information
  57. 8.10.2 Mylan Business Overview
  58. 8.10.3 Mylan Valsartan Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Mylan Valsartan Tablets Product Portfolio
  60. 8.10.5 Mylan Recent Developments
  61. 8.11 Teva
  62. 8.11.1 Teva Company Information
  63. 8.11.2 Teva Business Overview
  64. 8.11.3 Teva Valsartan Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Teva Valsartan Tablets Product Portfolio
  66. 8.11.5 Teva Recent Developments
  67. 8.12 Zhejiang Huahai Pharm
  68. 8.12.1 Zhejiang Huahai Pharm Company Information
  69. 8.12.2 Zhejiang Huahai Pharm Business Overview
  70. 8.12.3 Zhejiang Huahai Pharm Valsartan Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Zhejiang Huahai Pharm Valsartan Tablets Product Portfolio
  72. 8.12.5 Zhejiang Huahai Pharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valsartan Tablets Value Chain Analysis
  2. 9.1.1 Valsartan Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valsartan Tablets Sales Mode & Process
  6. 9.2 Valsartan Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valsartan Tablets Distributors
  9. 9.2.3 Valsartan Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst